Vaccines against tuberculosis: moving forward with new concepts.
作者信息
Gopal Radha, Khader Shabaana A
出版信息
Expert Rev Vaccines. 2013 Aug;12(8):829-31. doi: 10.1586/14760584.2013.814836. Epub 2013 Aug 14.
Abstract
摘要
相似文献
1
Vaccines against tuberculosis: moving forward with new concepts.抗结核疫苗：新观念引领前行
Expert Rev Vaccines. 2013 Aug;12(8):829-31. doi: 10.1586/14760584.2013.814836. Epub 2013 Aug 14.
2
Novel vaccine strategies against tuberculosis: a road less travelled.抗结核新型疫苗策略：一条鲜有人走的路。
Expert Rev Vaccines. 2013 Dec;12(12):1373-5. doi: 10.1586/14760584.2013.856766.
3
Mice continue to be a good model for preliminary assessment of tuberculosis vaccine candidates.小鼠仍然是初步评估结核病候选疫苗的良好模型。
Hum Vaccin Immunother. 2017 Mar 4;13(3):634-635. doi: 10.1080/21645515.2016.1248010. Epub 2016 Oct 20.
4
Recent developments in tuberculosis vaccines.结核病疫苗的最新进展。
Expert Rev Vaccines. 2013 Dec;12(12):1431-48. doi: 10.1586/14760584.2013.856765.
5
Toward Tuberculosis Vaccine Development: Recommendations for Nonhuman Primate Study Design.迈向结核病疫苗研发：非人类灵长类动物研究设计建议。
Infect Immun. 2018 Jan 22;86(2). doi: 10.1128/IAI.00776-17. Print 2018 Feb.
6
Tuberculosis vaccines: a strategic blueprint for the next decade.结核病疫苗：未来十年的战略蓝图。
Tuberculosis (Edinb). 2012 Mar;92 Suppl 1:S6-13. doi: 10.1016/S1472-9792(12)70005-7.
7
Planning in the context of a virtuous cycle for tuberculosis vaccine development.结核病疫苗研发良性循环背景下的规划
Tuberculosis (Edinb). 2012 Mar;92 Suppl 1:S4-5. doi: 10.1016/S1472-9792(12)70004-5.
8
The next 10 years for tuberculosis vaccines: do we have the right plans in place?未来 10 年的结核病疫苗：我们是否有合适的计划？
Expert Rev Vaccines. 2013 Apr;12(4):443-51. doi: 10.1586/erv.13.19.
9
MTBVAC from discovery to clinical trials in tuberculosis-endemic countries.MTBVAC从在结核病流行国家的发现到临床试验。
Expert Rev Vaccines. 2017 Jun;16(6):565-576. doi: 10.1080/14760584.2017.1324303. Epub 2017 May 12.
10
Tuberculosis vaccine development: Shifting focus amid increasing development challenges.结核病疫苗研发：在日益增加的研发挑战中转移重点。
Hum Vaccin Immunother. 2015;11(8):1910-6. doi: 10.1080/21645515.2015.1040955.
引用本文的文献
1
Tuberculosis vaccine developments and efficient delivery systems: A comprehensive appraisal.结核病疫苗研发与高效递送系统：全面评估
Heliyon. 2024 Feb 14;10(4):e26193. doi: 10.1016/j.heliyon.2024.e26193. eCollection 2024 Feb 29.
2
STAT2 Signaling Regulates Macrophage Phenotype During Influenza and Bacterial Super-Infection.STAT2 信号在流感和细菌双重感染期间调节巨噬细胞表型。
Front Immunol. 2018 Sep 25;9:2151. doi: 10.3389/fimmu.2018.02151. eCollection 2018.
3
Vaccine research and development: tuberculosis as a global health threat.疫苗研发：结核病作为一种全球健康威胁
Cent Eur J Immunol. 2017;42(2):196-204. doi: 10.5114/ceji.2017.69362. Epub 2017 Aug 8.
4
Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection.白细胞介素-17在抗高毒力结核分枝杆菌HN878感染的保护性免疫中的意外作用。
PLoS Pathog. 2014 May 15;10(5):e1004099. doi: 10.1371/journal.ppat.1004099. eCollection 2014 May.
5
Cutting Edge: MMP-9 inhibits IL-23p19 expression in dendritic cells by targeting membrane stem cell factor affecting lung IL-17 response.前沿：MMP-9 通过靶向影响肺 IL-17 反应的细胞膜干细胞因子来抑制树突状细胞中 IL-23p19 的表达。
J Immunol. 2014 Jun 15;192(12):5471-5475. doi: 10.4049/jimmunol.1303183. Epub 2014 May 14.
6
Novel vaccine approaches for protection against intracellular pathogens.新型疫苗方法预防细胞内病原体。
Curr Opin Immunol. 2014 Jun;28:58-63. doi: 10.1016/j.coi.2014.02.003. Epub 2014 Mar 6.
本文引用的文献
1
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.新型结核疫苗 MVA85A 在既往接种过卡介苗婴儿中的安全性和有效性：一项随机、安慰剂对照的 2b 期试验。
Lancet. 2013 Mar 23;381(9871):1021-8. doi: 10.1016/S0140-6736(13)60177-4.
2
Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults.新型结核疫苗 M72/AS01 在南非成年人中诱导和调节 T 细胞免疫。
Am J Respir Crit Care Med. 2013 Aug 15;188(4):492-502. doi: 10.1164/rccm.201208-1385OC.
3
Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis.白细胞介素-17 依赖性 CXCL13 介导黏膜疫苗诱导的抗结核免疫。
Mucosal Immunol. 2013 Sep;6(5):972-84. doi: 10.1038/mi.2012.135. Epub 2013 Jan 9.
4
Vaccination against tuberculosis: how can we better BCG?结核疫苗接种：我们如何更好地使用卡介苗？
Microb Pathog. 2013 May;58:2-16. doi: 10.1016/j.micpath.2012.12.002. Epub 2012 Dec 17.
5
Prospects for tuberculosis elimination.结核病消除的前景。
Annu Rev Public Health. 2013;34:271-86. doi: 10.1146/annurev-publhealth-031912-114431. Epub 2012 Dec 14.
6
Vaccine-induced th17 cells are maintained long-term postvaccination as a distinct and phenotypically stable memory subset.疫苗诱导的 Th17 细胞在接种疫苗后长期作为一个独特的、表型稳定的记忆亚群存在。
Infect Immun. 2012 Oct;80(10):3533-44. doi: 10.1128/IAI.00550-12. Epub 2012 Jul 30.
7
Improved CD4⁺ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: a randomized trial.与 M72/AS02 和 Mtb72F/AS02 结核候选疫苗制剂相比，M72/AS01 增强了 PPD 阴性成年人对结核分枝杆菌的 CD4+T 细胞反应：一项随机试验。
Vaccine. 2013 Apr 19;31(17):2196-206. doi: 10.1016/j.vaccine.2012.05.035. Epub 2012 May 27.
8
Vaccines against tuberculosis: where are we and where do we need to go?结核病疫苗：我们在哪里，我们需要去哪里？
PLoS Pathog. 2012;8(5):e1002607. doi: 10.1371/journal.ppat.1002607. Epub 2012 May 10.
9
A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity.表达免疫优势结核抗原的重组腺病毒可显著增强卡介苗诱导的人体免疫。
Vaccine. 2012 Mar 9;30(12):2098-108. doi: 10.1016/j.vaccine.2012.01.048. Epub 2012 Jan 30.
10
Recombinant BCG ΔureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses.重组卡介苗 ΔureC hly+ 通过刺激 1 型和 17 型细胞因子反应的平衡组合，诱导优于亲本卡介苗的保护作用。
J Infect Dis. 2011 Nov 15;204(10):1573-84. doi: 10.1093/infdis/jir592. Epub 2011 Sep 20.
Zotero 插件